Clinical Trial Update: A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD [Phase 3]

View source ↗

Summary

A Phase 3 double-blind study is assessing the safety and efficacy of Buntanetap in participants with early Alzheimer's disease. The trial is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Buntanetap

Snippet

Sponsor: Annovis Bio Inc. | Conditions: Early Alzheimers Disease | Phase 3 | Status: RECRUITING